News

Physician's Weekly20m
Assessing Dementia Diagnosis Accuracy With Informant Questionnaires
The following is a summary of “Informant accuracy of IQCODE, AD8 and GPCOGi for diagnosis of dementia: does your friend know ...
Physician's Weekly43m
Impact of COVID-19 on Austrian Primary Care Physicians’ Resource and Care Quality Assessments
The following is a summary of “How Austrian primary care physicians evaluated their available resources and quality of care ...
Physician's Weekly1h
Impact of Social Comparison Orientation on Social Anxiety in Survivors With Breast Cancer
The following is a summary of “Role of social comparative orientation in social anxiety among breast cancer survivors: a ...
Physician's Weekly1h
Negative Expectations and Pain Responses After SMH
The following is a summary of “Nocebo Effect on Pain-Related Autonomic Responses in a State of Experimentally-Induced ...
Physician's Weekly2h
Q&A: Tiny, Bioresorbable Pacemaker May Transform Cardiac Rhythm Management
Dr. Eric Rytkin discusses the clinical need for—and significant advantages of—his team’s recently unveiled millimeter-scale, ...
Physician's Weekly4h
2019 to 2023 Saw Increase in Prevalence of Psilocybin Use in the United States
The prevalence of lifetime and past-year use of psilocybin increased from 2019 to 2023 among all age groups in the United ...
Physician's Weekly4h
Nearly One in Four Families of Children With Disabilities Face Financial Hardships
Families of children with disabilities have a nearly doubled likelihood of experiencing financial hardships versus families ...
Physician's Weekly4h
CDC Provides Update on Measles Outbreak in the United States
Eight hundred cases of measles were reported in the United States as of April 17, 2025, representing the second highest ...
Physician's Weekly4h
Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
Patients with cancer aged 65 years and older receiving immune checkpoint inhibitors (ICIs) derive similar clinical outcomes ...
Physician's Weekly4h
Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk
An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among ...
Physician's Weekly4h
FDA Approves Zevaskyn for Rare, Genetic Skin Disorder
The U.S. Food and Drug Administration has approved Zevaskyn (prademagene zamikeracel) for patients with the rare, genetic ...
Physician's Weekly4h
Food Companies Race to Replace Artificial Colors With Natural Alternatives
The push to remove artificial colors from U.S. foods is gaining speed, but making the change won't be easy — or quick. Last ...